Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study. (Q48571866)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study. |
scientific article |
Statements
1 reference
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study. (English)
1 reference
1 reference
Harry J M Groen
1 reference
Hannie Sietsma
1 reference
Andrew Vincent
1 reference
Monique M H Hochstenbag
1 reference
John W G van Putten
1 reference
Otilia Dalesio
1 reference
Bonne Biesma
1 reference
Hans J M Smit
1 reference
Ariën Termeer
1 reference
T Jeroen N Hiltermann
1 reference
Ben E E M van den Borne
1 reference
Franz M N H Schramel
1 reference
11 October 2011
1 reference
1 reference
29
1 reference
32
1 reference
4320-4326
1 reference
Identifiers
1 reference
1 reference